PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 141 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,556,000 | -73.1% | 144,624 | -68.2% | 0.20% | -50.2% |
| Q2 2019 | $5,774,000 | -73.9% | 454,300 | -20.4% | 0.40% | -61.0% |
| Q1 2019 | $22,141,000 | +129.5% | 570,800 | +20.4% | 1.02% | +54.1% |
| Q4 2018 | $9,647,000 | +147.3% | 474,100 | +457.1% | 0.66% | +198.2% |
| Q3 2018 | $3,901,000 | -22.5% | 85,100 | 0.0% | 0.22% | -24.4% |
| Q2 2018 | $5,033,000 | +158.5% | 85,100 | +332.0% | 0.30% | +183.7% |
| Q4 2017 | $1,947,000 | -46.6% | 19,700 | -83.4% | 0.10% | -65.3% |
| Q4 2016 | $3,644,000 | – | 118,700 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
| Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
| Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
| Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
| J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
| FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
| JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |